Cannara Biotech Inc(LOVE-T)
TSX

Today's Change
Real-Time Last Update
Day Low1.85
Day High1.92
Open:1.90
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
SYNDTGAM
Small caps to watch: Electrovaya shares surge on Amazon deal plus updates from NFI, Canfor, Mattr, Aecon, Bird Construction and more
Our roundup of Canadian small-caps in the news today.
GlobeNewswire
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
Baystreet
Stocks in play: Cannara Biotech Inc.
GlobeNewswire
Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited
GlobeNewswire
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
GlobeNewswire
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology
Stock Target Advisor
Canadian Analyst Updates: May 6th, 2026
Canadian Analyst Updates: May 6th, 2026
GlobeNewswire
Cannara Completes Acquisition of Medican Organic Inc.
Baystreet
Stocks in play: Cannara Biotech Inc.
GlobeNewswire
Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec
Baystreet
Stocks in play: Cannara Biotech Inc.
GlobeNewswire
Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026
Newsfile
Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange
B-TV.com
CEO Clips - Cannara Biotech Expands Cannabis Production with Mega Facilities
CEO Clips - Cannara Biotech Expands Cannabis Production with Mega Facilities
Newsfile
Cannara Biotech Inc. (LOVE) ouvre les marchés

Profile

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.